Does MOMETASONE Cause Therapeutic product effect incomplete? 400 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 400 reports of Therapeutic product effect incomplete have been filed in association with MOMETASONE (MOMETASONE FUROATE). This represents 23.7% of all adverse event reports for MOMETASONE.
400
Reports of Therapeutic product effect incomplete with MOMETASONE
23.7%
of all MOMETASONE reports
1
Deaths
248
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From MOMETASONE?
Of the 400 reports, 1 (0.3%) resulted in death, 248 (62.0%) required hospitalization, and 6 (1.5%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOMETASONE. However, 400 reports have been filed with the FAERS database.
What Other Side Effects Does MOMETASONE Cause?
Asthma (522)
Dyspnoea (497)
Wheezing (459)
Gastrooesophageal reflux disease (406)
Drug ineffective (318)
Sleep disorder due to a general medical condition (318)
Cardiac disorder (311)
Headache (308)
Loss of personal independence in daily activities (301)
Cough (294)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which MOMETASONE Alternatives Have Lower Therapeutic product effect incomplete Risk?
MOMETASONE vs MOMETASONE FUROATE
MOMETASONE vs MOMETASONE FUROATE\OLOPATADINE
MOMETASONE vs MONOMETHYL
MOMETASONE vs MONTELUKAST
MOMETASONE vs MONTELUKAST\MONTELUKAST